Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Immunotech Biopharm Ltd ( (HK:6978) ) has shared an update.
Immunotech Biopharm Ltd has announced that its board of directors will meet on March 28, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is crucial as it will determine the financial performance of the company and could influence its market positioning and stakeholder confidence.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biotechnology company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative biopharmaceutical products. The company operates within the pharmaceutical industry, with a market focus on developing treatments and therapies for various medical conditions.
YTD Price Performance: 87.39%
Average Trading Volume: 611,035
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.43B
For an in-depth examination of 6978 stock, go to TipRanks’ Stock Analysis page.